A detailed history of Avanza Fonder Ab transactions in Amgen Inc stock. As of the latest transaction made, Avanza Fonder Ab holds 59,122 shares of AMGN stock, worth $15.9 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares
59,122
Holding current value
$15.9 Million
% of portfolio
0.46%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 15, 2025

BUY
$258.78 - $328.31 $15.3 Million - $19.4 Million
59,122 New
59,122 $15.4 Billion

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $144B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Avanza Fonder Ab Portfolio

Follow Avanza Fonder Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avanza Fonder Ab, based on Form 13F filings with the SEC.

News

Stay updated on Avanza Fonder Ab with notifications on news.